1
|
Dato GA, Picichè M. Off-pump Techniques of Surgical Myocardial Revascularization. Rev Recent Clin Trials 2019; 14:116-119. [PMID: 30706790 DOI: 10.2174/1574887114666190201112053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Revised: 03/22/2018] [Accepted: 05/12/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND Before the advent of CABG, standardized in the late '60s by Favaloro and Effler, patients with myocardial ischemia underwent indirect and heterogeneous off-pump methods of myocardial revascularization. METHODS & RESULTS Indirect revascularization, such as periaortic nerve plexus interruption, Vineberg operation, Sen procedure and, less remotely, TMR Laser and stem cell transplantation, represented some of the ways to achieve myocardial revascularization. Nowadays, direct coronary revascularization is the only established technique and may be performed either on-pump or off-pump. CONCLUSION The comparison of off-pump and on-pump myocardial revascularization paved the way to an endless debate between the advantages and disadvantages of each technique. In this article, we review the old and current off-pump approaches of surgical myocardial revascularization.
Collapse
Affiliation(s)
- Guglielmo Actis Dato
- Cardiac Surgery Department, Mauriziano Hospital, Largo Turati, 10131, Turin, Italy
| | - Marco Picichè
- Cardiac Surgery Department, Aulss8 Berica, San Bortolo Hospital, Via F. Rodolfi 37, 36100, Vicenza, Italy
| |
Collapse
|
2
|
Crystal RG, Kaminsky SM, Hackett NR, Rosengart TK. Double-blinded, placebo-controlled, randomized gene therapy using surgery for vector delivery. Hum Gene Ther 2012; 23:438-41. [PMID: 22452798 DOI: 10.1089/hum.2012.062] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- Ronald G Crystal
- Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
| | | | | | | |
Collapse
|
3
|
Shen M, Gao J, Li J, Su J. Effect of stimulation frequency on angiogenesis and gene expression in ischemic skeletal muscle of rabbit. Can J Physiol Pharmacol 2009; 87:396-401. [PMID: 19448738 DOI: 10.1139/y09-007] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
To examine the comparative effects of different frequencies of electrical stimulation (ES) on angiogenesis and gene expression, New Zealand white rabbits with femoral artery ligation in one hindlimb and electrode implantation on the sciatic nerve of the same hindlimb were randomly assigned to 4 groups: control group, 1 Hz group, 10 Hz group, and 40 Hz group. The ES procedure involved 5 min stimulation, followed by 5 min rest, repeated 8 times daily for 4 consecutive weeks. The resting blood flow (RBF) was measured via the microspheres technique. Collateralization was evaluated by immunohistochemistry. Angiogenic factors were analyzed by real-time RT-PCR. Both RBF and capillary density were significantly increased in the 10 Hz and 40 Hz groups, but were not changed in the 1 Hz group. Vascular endothelial growth factor (VEGF) mRNA was highest in the 40 Hz group. Hypoxia-inducible factor 1alpha (HIF-1alpha) mRNA was significantly elevated only in the 40 Hz group. VEGF receptor fetal liver kinase 1 (Flk-1) mRNA was upregulated equally in the 10 Hz and 40 Hz groups, but fibroblast growth factor 2 (FGF-2) mRNA did not change in any group. Our results suggest that the optimal frequency of ES for angiogenesis is within the 10-40 Hz range.
Collapse
Affiliation(s)
- Mei Shen
- Department of Rehabilitation Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China
| | | | | | | |
Collapse
|
4
|
Effect of ischaemic exercise training of a normal limb on angiogenesis of a pathological ischaemic limb in rabbits. Clin Sci (Lond) 2009; 117:201-8. [PMID: 19125697 DOI: 10.1042/cs20080212] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The present study was designed to test the hypothesis that local exercise of a normal limb can promote angiogenesis in a pathological ischaemic limb. New Zealand White rabbits underwent left femoral artery ligation (Lig) and electrode implantation on the right sciatic nerve. The rabbits were randomly assigned to four groups: (i) Lig-N group, which did not receive ES (electrical stimulation); (ii) Lig-High group, which received high-intensity ES (2.5 mA, 40Hz for 1 ms) on the right hindlimb; (iii) Lig-Low group, which received low-intensity ES (0.3 mA, 40Hz for 1 ms) on the right hindlimb; (iv) Double-Lig-High group, which underwent femoral artery ligation on both hindlimbs and received high-intensity ES (2.5 mA, 40Hz for 1 ms) on the right hindlimb. The ES procedure included 5 min of stimulation, followed by 5 min of rest, and was repeated eight times a day for 4 weeks. Collateral circulation was examined grossly by angiography, resting blood flow was measured using the microspheres technique, and capillary supply was evaluated by immunohistochemistry. VEGF (vascular endothelial growth factor) mRNA and protein were analysed by real-time RT (reverse transcription)–PCR and Western blotting respectively. Collateral blood flow in all of the major muscles of the left hindlimb in the Lig-High group was highest among the four groups (P<0.01). Capillary supply (P<0.001), VEGF mRNA (P<0.01) and VEGF protein (P<0.01) in the gastrocnemius muscle increased remarkably in the Lig-High group; no statistically significant difference was observed among the other three groups. In conclusion, angiogenesis associated with an up-regulation of VEGF expression in pathological ischaemic limb may be facilitated by 4 weeks of physiological ischaemic exercise training in a normal limb.
Collapse
|
5
|
Effect and mechanism of intermittent myocardial ischemia induced by exercise on coronary collateral formation. Am J Phys Med Rehabil 2008; 87:803-14. [PMID: 18688201 DOI: 10.1097/phm.0b013e31817faed0] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To hypothesize that appropriate intermittent myocardial ischemia induced by exercise could safely promote coronary collateral formation in the ischemic area through the increased expression of vascular endothelial growth factor (VEGF) and its receptor fetal liver kinase-1 (Flk-1). DESIGN A balloon constrictor was surgically implanted in the first obtuse marginal coronary artery (OM1) of Guangxi BA-MA miniature pigs. The subjects were divided into three groups: sham-operated (SO), pure ischemia (PI), and exercise training (ET). Subjects in the ET group performed individualized treadmill programs with two episodes of exercise-induced ischemia for 8 wks; two preexercise episodes of pure ischemia induced by brief OM1 occlusion were also conducted. Only pure ischemia was induced in the PI group, and the SO group remained sedentary for the experimental period. VEGF and Flk-1 expression levels were measured by Western blot and real-time reverse transcription polymerase chain reaction analyses; capillary density by immunohistochemistry; relative myocardial blood flow by microspheres; and cardiac troponin I by enzyme-linked immunosorbent assay. RESULTS The relative myocardial blood flow, VEGF, Flk-1, and capillary density in the ET group were statistically higher than those in the PI and SO groups. All parameters in the PI group were statistically higher than those in the SO group. There was no myocardial damage in the ET or PI groups by cardiac troponin I. CONCLUSIONS Intermittent myocardial ischemia induced by exercise with optimal stimulation safely promotes coronary collateral formation through increased VEGF and Flk-1 expression in a porcine model.
Collapse
|
6
|
Abstract
It has been almost a decade since transmyocardial laser revascularization (TMR) was approved for clinical use in the United States. The safety of TMR was demonstrated initially with nonrandomized studies in which TMR was used as the only treatment for patients with severe angina. TMR efficacy was proven after multiple randomized controlled trials. These revealed significant angina relief compared to maximum medical therapy in patients with diffuse coronary disease not amenable to conventional revascularization. In light of these results, TMR has been used as an adjunct to coronary artery bypass grafting (CABG). By definition, patients treated with this combined therapy have more severe coronary disease and comorbidities that are associated with end-stage atherosclerosis. Combination CABG + TMR has resulted in symptomatic improvement without additional risk. The likely mechanism whereby TMR has provided benefit is the angiogenesis engendered by the laser-tissue interaction. Improved perfusion and concomitant improvement in myocardial function have been observed post-TMR. Additional therapies to enhance the angiogenic response include combining TMR with stem cell-based treatments, which appear to be promising future endeavors.
Collapse
Affiliation(s)
- Keith A Horvath
- Cardiothoracic Surgery Research, National Heart, Lung and Blood Institute/NIH, Bethesda, Maryland 20892, USA.
| |
Collapse
|
7
|
Spiegelstein D, Kim C, Zhang Y, Li G, Weisel RD, Li RK, Yau TM. Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival. Am J Physiol Heart Circ Physiol 2007; 293:H3311-6. [PMID: 17827264 DOI: 10.1152/ajpheart.00178.2007] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We hypothesized that pretreatment of an infarcted heart by mechanical transmyocardial revascularization (TMR) before transplantation of bone marrow cells (BMCs) or BMC-expressing angiogenic growth factors would increase transplanted BMC survival and enhance myocardial repair. Female Lewis rats underwent coronary ligation 3 wk before creation of 10 needle TMR channels (3 groups) or no TMR (3 groups), followed by transplantation of 3 × 106male donor BMCs, BMC transfected with vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and insulin-like growth factor-1 (IGF-1) (BMC + VBI), or medium alone. At 1, 3, and 7 days, we evaluated transplanted cell survival, vascular densities, and left ventricular (LV) function ( N = 4 per group × 6 groups × 3 time points). At 3 days, vascular densities in the scar were increased by TMR + BMC + VBI and by BMC + VBI ( P < 0.05), and at 7 days, vascular densities were greatest in rats receiving TMR + BMC + VBI ( P < 0.05). Transplanted cell survival at 3 and 7 days was increased by TMR and by BMC + VBI. Combined therapy with TMR + BMC + VBI resulted in the greatest cell survival at 3 days ( P < 0.05) versus BMC. After 7 days, LV ejection fraction (LVEF) was lowest in rats receiving neither BMC nor TMR and greatest in rats receiving TMR + BMC + VBI ( P = 0.004). We concluded that mechanical pretreatment of infarcted myocardium by TMR enhances the effect of subsequent cell-based gene therapy on transplanted cell survival, angiogenesis, and LV function. Scar pretreatment with TMR combined with cell-based multigene therapy may maximize myocardial repair.
Collapse
Affiliation(s)
- Dan Spiegelstein
- Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, 200 Elizabeth Street, Toronto, Ontario, Canada
| | | | | | | | | | | | | |
Collapse
|
8
|
Chiu RCJ. From "spongy" and "cold" hearts to cellular cardiomyoplasty: tales of Canadian contribution to global cardiac surgery. World J Surg 2007; 31:1563-8. [PMID: 17594123 DOI: 10.1007/s00268-007-9138-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Despite the small size of its population and the number of its cardiac surgeons, Canadians have participated actively in the birth and development of cardiac surgery during the past half century, with pioneers such as Arthur Vineberg and Wilfred Bigelow leading the way. New and innovative cardiac surgical techniques and their scientific bases were developed and shared globally over the years. Canadian surgeons continue to be productive and are contributing to advances in this field at the dawn of the twenty-first century. Some of these efforts and achievements are illustrated in this review.
Collapse
Affiliation(s)
- Ray C-J Chiu
- Division of Cardiac Surgery, Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada.
| |
Collapse
|
9
|
Abstract
OBJECTIVE The creation of new coronary arteries has long been an objective of cardiac research. I describe a method for creating new blood vessels in the myocardium of the left ventricular wall in animals. METHODS The myocardium was pierced by a fistula. Then a biodegradable hydrogel fiber with antithrombogenic and nonadhesive properties was inserted into the fistula with a venous catheter. Nine dogs were used. Three fibers were inserted in each heart, and two additional punctures were made and left empty as controls. RESULTS During absorption of the fiber, the luminal surface of the fistula became lined with endothelial cells and developed many openings to capillary blood vessels of the myocardium naturally. Three straight fibers were inserted so they intersected in the myocardium. They created a new branched vessel. The fistulas had connections to original coronary arteries and worked as new arteries to supply blood to the area where they were created. CONCLUSIONS It was possible to create new blood vessels in the myocardium in animals.
Collapse
Affiliation(s)
- Yasuharu Noishiki
- Division of Artificial Organ Science, Graduate School of Medicine, Yokohama City University, Japan.
| |
Collapse
|
10
|
Wang Y, Dong Y, Li R, Wang D, Tang H, Liu W, Zhang X. Transmyocardial revascularization and vascular endothelial growth factor administration enhance effect of cell transplantation for myocardial infarct repair in rats. Coron Artery Dis 2006; 17:275-81. [PMID: 16728879 DOI: 10.1097/00019501-200605000-00012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To test the hypothesis that transmyocardial revascularization and vascular endothelial growth factor (VEGF) administration would enhance cell transplantation effect for myocardial infarct. METHODS After ligation of left anterior descending coronary artery, the recipient rats were treated with transmyocardial revascularization. Ten minutes after transmyocardial revascularization, recombinant murine VEGF165 was injected into the clot of the drilling channel and the myocardium bordering the channel. Two weeks after transmyocardial revascularization, differentiated cells from embryo stem cells were injected into the infarcted myocardium and vascular endothelial growth factor was injected again in the same dose. Four weeks after the differentiated cells were grafted, cardiac function was assessed by hemodynamic measurements. Capillary density and infarct size in the infarct region were measured with a previous experimental method. Graft histology and morphology were also evaluated. RESULTS Four weeks after the differentiated cells were grafted, myocardial infarct rats treated with transmyocardial revascularization and vascular endothelial growth factor showed a significantly higher cardiac function in hemodynamic measurements (P<0.01) than other control groups. A significant increase in capillary density and reduction in infarct size were observed in the infarct hearts of the myocardial infarct rats under combination therapy (P<0.01). CONCLUSIONS Before differentiated cell transplantation, transmyocardial revascularization and vascular endothelial growth factor administration caused an angiogenesis effect to enhance neovascularization. It may be superior in attenuating the progression of cardiac dysfunction in the rat model compared with the myocardial infarct rat transplanted cell alone.
Collapse
Affiliation(s)
- Yanmei Wang
- Department of Anatomy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| | | | | | | | | | | | | |
Collapse
|
11
|
Wang Y, Tang H, Wang D, Li R, Dong Y, Liu W, Zhang X. Pretreatment With Transmyocardial Revascularization Might Improve Ischemic Myocardial Function Performed With Cell Transplantation. Circ J 2006; 70:625-30. [PMID: 16636501 DOI: 10.1253/circj.70.625] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Cells transplanted into the myocardial infarct areas might be lost because of the lack of blood supply to these myocardium areas. The hypothesis that pretreatment with angiogenic therapy induced by transmyocardial revascularization (TMR) might improve ischemic myocardial function, followed by cell transplantation was tested. METHODS AND RESULTS After the ligation of the left anterior descending coronary artery, rats were treated with TMR. Two weeks, embryonic stem cells were transplanted into an injured heart. Four weeks after cell transplantation, cardiac function was assessed by homodynamic measurements. Capillary density and infarct size in the infarct myocardium were measured by using a previous experimental method. Graft histology and morphology was also evaluated. Four weeks after the operation, myocardial infarct (MI) rats treated with TMR and cell transplantation showed significantly higher cardiac function in hemodynamic measurements (p < 0.01) than that of MI rats receiving cell transplantation or TMR alone. A significant increase in capillary density and reduction in infarct size was observed in the MI rats that received a combined therapy (p < 0.01). CONCLUSION Pretreatment of an infarct region of the heart with angiogenesis induced by TMR can enhance the efficacy of a cell graft and attenuate the progression of cardiac dysfunction in the rat model.
Collapse
Affiliation(s)
- Yanmei Wang
- Department of Anatomy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| | | | | | | | | | | | | |
Collapse
|
12
|
Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC, Kormos R, Benetti F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005; 130:1631-8. [PMID: 16308009 DOI: 10.1016/j.jtcvs.2005.07.056] [Citation(s) in RCA: 210] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2004] [Revised: 07/06/2005] [Accepted: 07/12/2005] [Indexed: 11/26/2022]
Abstract
BACKGROUND Autologous adult stem cell transplantation has been touted as the latest tool in regenerative medical therapy. Its potential for use in cardiovascular disease has only recently been recognized. A randomized study was conducted with a novel epicardial technique to deploy stem cells as an adjuvant to conventional revascularization therapy in patients with congestive heart failure. METHODS After institutional review board and government approval, adult autologous stem cell transplantation (CD34+) was performed in patients with ischemic cardiomyopathy and an ejection fraction of less than 35% who were scheduled for primary off-pump coronary artery bypass grafting. Preoperatively, the patients underwent echocardiography, stress thallium imaging single photon emission computed tomography, and cardiac catheterization to identify ischemic regions of the heart and to guide in the selection of stem cell injection sites. The patients were prospectively randomized before the operative therapy was performed. Patient follow-up was 1, 3, and 6 months with echocardiography, single photon emission computed tomography, and angiography. RESULTS There were 20 patients enrolled in the study. Ten patients had successful subepicardial transplantation of autologous stem cells into ischemic myocardium. The other 10 patients, the control group, only had off-pump coronary artery bypass grafting. There were 8 male and 2 female subjects in each group. The median number of grafts performed was 1 in both groups. On angiographic follow-up, all grafts were patent at 6 months. The ejection fractions of the off-pump coronary artery bypass grafting group versus the off-pump coronary artery bypass grafting plus stem cell transplantation group were as follows: preoperative, 30.7% +/- 2.5% versus 29.4% +/- 3.6%; 1 month, 36.4% +/- 2.6% versus 42.1% +/- 3.5%; 3 months, 36.5% +/- 3.0% versus 45.5% +/- 2.2%; and 6 months, 37.2% +/- 3.4% versus 46.1% +/- 1.9% (P < .001). There were no perioperative arrhythmias or neurologic or ischemic myocardial events in either group. CONCLUSIONS Autologous stem cell transplantation led to significant improvement in cardiac function in patients undergoing off-pump coronary artery bypass grafting for ischemic cardiomyopathy. Further investigation is required to quantify the optimal timing and specific cellular effects of the therapy.
Collapse
Affiliation(s)
- Amit N Patel
- Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pa, USA.
| | | | | | | | | | | | | |
Collapse
|
13
|
Bridges CR, Horvath KA, Nugent WC, Shahian DM, Haan CK, Shemin RJ, Allen KB, Edwards FH. The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization. Ann Thorac Surg 2004; 77:1494-502. [PMID: 15063304 DOI: 10.1016/j.athoracsur.2004.01.007] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/14/2004] [Indexed: 10/26/2022]
Abstract
BACKGROUND Patients with chronic severe angina refractory to medical therapy who cannot be completely revascularized with either percutaneous catheter intervention or coronary artery bypass graft surgery present clinical challenges. Transmyocardial laser revascularization, either as sole therapy or as an adjunct to coronary artery bypass graft surgery, may be appropriate for some of these patients. Although transmyocardial revascularization has consistently been demonstrated as an efficacious means of relieving angina, the mechanism of its effects are still debated, and criteria for the selection of patients for this novel therapy have not been adequately defined. METHODS We reviewed the available evidence to allow us to make recommendations for the appropriate therapeutic applications of transmyocardial revascularization following the format of the American Heart Association and the American College of Cardiology guidelines for diagnostic and therapeutic procedures. Our recommendations were classified as class I, IIA, IIB, or III. For each recommendation we defined the level of supporting evidence as A, B, or C. RESULTS We identified class I indications for transmyocardial revascularization as sole therapy and class IIA indications for transmyocardial revascularization as an adjunct to coronary artery bypass graft surgery with levels of evidence A and B, respectively. CONCLUSIONS Transmyocardial laser revascularization may be an acceptable form of therapy for selected patients: as sole therapy for a subset of patients with refractory angina and as an adjunct to coronary artery bypass graft surgery for a subset of patients with angina who cannot be completely revascularized surgically.
Collapse
Affiliation(s)
- Charles R Bridges
- Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Affiliation(s)
- Subroto Paul
- Department of Surgery, Brigham and Women's Hospital, Boston 02115, USA
| | | | | | | |
Collapse
|
15
|
Abstract
BACKGROUND The application of ultrasound to microbubbles in skeletal muscle creates capillary ruptures. We tested the hypothesis that this bioeffect could be used to stimulate the growth and remodeling of new arterioles via natural repair processes, resulting in an increase in skeletal muscle nutrient blood flow. METHODS AND RESULTS Pulsed ultrasound (1 MHz) was applied to exposed rat gracilis muscle after intravenous microbubble injection. Capillary rupturing was visually verified by the presence of red blood cells in the muscle, and animals were allowed to recover. Ultrasound-microbubble-treated and contralateral sham-treated muscles were harvested 3, 7, 14, and 28 days later. Arterioles were assessed by smooth muscle alpha-actin staining, and skeletal muscle blood flow was measured with 15- micro m fluorescent microspheres. An approximately 65% increase in arterioles per muscle fiber was noted in treated muscles compared with paired sham-treated control muscles at 7 and 14 days after treatment. This increase in arterioles occurred across all studied diameter ranges at both 7 and 14 days after treatment. Arterioles per muscle fiber in sham-treated and untreated control muscles were comparable, indicating that the surgical intervention itself had no significant effect. Hyperemia nutrient blood flow in treated muscles was increased 57% over that in paired sham-treated control muscles. CONCLUSIONS Capillary rupturing via microbubble destruction with ultrasound enhances arterioles per muscle fiber, arteriole diameters, and maximum nutrient blood flow in skeletal muscle. This method has the potential to become a clinical tool for stimulating blood flow to organs affected by occlusive vascular disease.
Collapse
Affiliation(s)
- Ji Song
- Department of Biomedical Engineering, University of Virginia, Charlottesville 22908, USA
| | | | | | | |
Collapse
|
16
|
Fuchs S, Baffour R, Vodovotz Y, Shou M, Stabile E, Tio FO, Leon MB, Kornowski R. Laser myocardial revascularization modulates expression of angiogenic, neuronal, and inflammatory cytokines in a porcine model of chronic myocardial ischemia. J Card Surg 2002; 17:413-24. [PMID: 12630542 DOI: 10.1111/j.1540-8191.2001.tb01171.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Controversy exists whether transmyocardial laser revascularization (TMR) is associated with angiogenesis or neuromodulation and whether these are time-dependent phenomena. Accordingly, we performed a time-course analysis of the expression of angiogenic and neuronal factors following experimental percutaneous TMR. METHODS AND RESULTS Five weeks after placing ameroid constrictors on the circumflex coronary artery, 16 pigs underwent left ventricular mapping guided TMR using Ho:YAG laser (2 J x 1 pulse) at 30 sites directed at the ischemic zones and 11 animals were ischemic controls. Histology and immunostaining were obtained at 1 and 2 weeks (4 TMR and 3 controls at each time point) and at 4 weeks (8 TMR and 5 controls) for vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), nerve growth factor (betaNGF), substance P (SP), and monocyte chemoattractant protein-1 (MCP-1). Immunoreactivity was scored using a digital image analysis system. Factor VIII staining was used for blood vessel counting. Enhanced regional expression of VEGF, bFGF and MCP-1 in the TMR group was noted at 1 and 2 weeks with a threefold increase at 4 weeks following TMR compared to controls. BetaNGF expression in the TMR group was enhanced at 1 and 2 weeks with subsequent decline at 4 weeks to the controls level. SP expression was not significantly different between groups at all time points. There was a twofold increase in the number of blood vessels in the TMR group at 4 weeks, which was not apparent earlier. CONCLUSIONS These immunohistological findings suggest that cytokines expression compatible with angiogenesis and neuromodulation occurs early after TMR. Up-regulation of angiogenic and inflammatory cytokines may be more sustained than neuromodulation.
Collapse
Affiliation(s)
- Shmuel Fuchs
- Cardiovascular Research Institute,Washington Hospital Center, Washington, DC 20010, USA.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Huikeshoven M, Beek JF, van der Sloot JAP, Tukkie R, van der Meulen J, van Gemert MJC. 35 years of experimental research in transmyocardial revascularization: what have we learned? Ann Thorac Surg 2002; 74:956-70. [PMID: 12238883 DOI: 10.1016/s0003-4975(01)03547-0] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
In the past 35 years many experimental studies have been performed to investigate the revascularization potential of transmyocardial revascularization and the possible working mechanisms underlying the observed clinical improvement in angina pectoris after this treatment. In this review of the experimental literature, the various methods that have been used to create transmyocardial channels and the most supported hypotheses on the working mechanism (channel patency, angiogenesis and myocardial denervation) are discussed and evaluated.
Collapse
Affiliation(s)
- Menno Huikeshoven
- Laser Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
| | | | | | | | | | | |
Collapse
|
18
|
Price RJ, Kaul S. Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J Cardiovasc Pharmacol Ther 2002; 7:171-80. [PMID: 12232566 DOI: 10.1177/107424840200700307] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
The effective delivery of intravascular drugs and genes to regions of pathology is dependent on a number of factors that are often difficult to control. Foremost is the site-specific delivery of the payload to the region of pathology and the subsequent transport of the payload across the endothelial barrier. Ultrasound contrast agent microbubbles, which are typically used for image enhancement, are capable of amplifying both the targeting and transport of drugs and genes to tissue. Microbubble targeting can be achieved by the intrinsic binding properties of the microbubble shells or through the attachment of site-specific ligands. Once microbubbles have been targeted to the region of interest, microvessel walls can be permeabilized by destroying the microbubbles with low-frequency, high-power ultrasound. A second level of targeting specificity can be achieved by carefully controlling the ultrasound field and limiting microbubble destruction to the region of interest. When microbubbles are destroyed, drugs or genes that are housed within them or bound to their shells can be released to the blood stream and then delivered to tissue by convective forces through the permeabilized microvessels. An alternative strategy is to increase payload volume by coinjecting drug- or gene-bearing vehicles, such as liposomes, with the microbubbles. In this manifestation, microbubbles are used for creating sites of microvessel permeabilization that facilitate drug or gene vehicle transport. Recent work in the emerging field of contrast ultrasound-based therapeutics, with particular emphasis on the delivery of drugs and genes to tissue through microvascular networks is reviewed.
Collapse
Affiliation(s)
- Richard J Price
- Department of Biomedical Engineering, University of Virginia, Health Sciences Center, Charlottesville, VA 22908, USA
| | | |
Collapse
|
19
|
Hughes GC, Biswas SS, Yin B, Baklanov DV, Annex BH, Coleman RE, DeGrado TR, Landolfo CK, Landolfo KP, Lowe JE. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol 2002; 39:1220-8. [PMID: 11923050 DOI: 10.1016/s0735-1097(02)01734-5] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES The purpose of the present study was to compare the use of a mechanical transmyocardial implant (TMI) device with transmyocardial laser revascularization (TMR) for induction of therapeutic angiogenesis and arteriogenesis in the chronically ischemic heart. BACKGROUND Prior experimental studies have demonstrated evidence for neovascularization after both mechanical and laser transmyocardial revascularization, although a long-term comparison of the two techniques has not been performed. METHODS Using an established model of chronic hibernating myocardium, mini-swine underwent 90% proximal left circumflex (LCx) coronary artery stenosis. One month later, baseline positron emission tomography (PET) and dobutamine stress echocardiography (DSE) were performed to quantitate regional myocardial blood flow (MBF) and function. Animals then underwent TMR with a holmium:yttrium-aluminum-garnet (holmium:YAG) laser (n = 5), TMI (n = 5), or sham redo-thoracotomy (n = 5). In the TMR group, the entire LCx region was treated with transmural laser channels at a density of 1/cm(2). Transmyocardial implants were placed transmurally at a similar density in the LCx region of the TMI group. Six months later, the PET and DSE studies were repeated, and the animals were euthanized. RESULTS Six months after TMR, there was a significant increase over baseline in resting MBF to the lased LCx region (68.9 +/- 4.6% vs. 89.3 +/- 3.0% reference non-ischemic septal segments; p < 0.001). This increased MBF was accompanied by a significant improvement in LCx regional wall motion during peak dobutamine stress (p = 0.04). Compared with baseline, there was no change in LCx region MBF six months after either TMI (72.9 +/- 4.8% vs. 85.7 +/- 3.4%; p = 0.10) or sham redo-thoracotomy (75.6 +/- 4.6% vs. 80.1 +/- 5.0%; p > 0.2). Likewise, there was no significant change in rest or stress wall motion by DSE six months postoperatively in either group. Overall vascular density was increased only in the TMR-treated regions six months postoperatively. The difference between groups was most notable for a twofold increase in the number of small arterioles seen in the lased (4.4 +/- 0.3 arterioles per high power field; p < 0.001 vs. both TMI and sham) compared with TMI (2.2 +/- 0.2) and sham (1.9 +/- 0.2)-treated regions. CONCLUSIONS Mechanical transmyocardial revascularization with a TMI device does not appear to promote physiologically significant angiogenesis or arteriogenesis in the chronically ischemic porcine heart and cannot be recommended for clinical trials at this time. Infrared laser-mediated injury mechanisms may be important for inducing therapeutic neovascularization with direct myocardial revascularization techniques.
Collapse
Affiliation(s)
- G Chad Hughes
- Department of Surgery, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Abstract
Along with angiogenesis and gene therapy, cell transplantation is one of the newest treatment modalities proposed to improve the outcome of patients with cardiac failure. Both experimental and clinical data have now established that implantation of contractile cells into fibrous postinfarction scars can allow them to regain some functionality. Primarily for practical reasons, autologous skeletal myoblasts have been the first to be tested in a clinical trial, but other cell types can be considered among which bone marrow stromal and hematopoietic stem cells are of particular interest because of their presumed pluripotentiality and the possibility to use them as autografts. However, several key issues still need to be addressed including: (1) the advantages and disadvantages of these different donor cells; (2) the extent to which cell engraftment affects cardiac function actively (ie, by increasing contractility) or passively (ie, by limiting infarct expansion and remodeling); (3) the development of strategies targeted at enhancing cell survival; and (4) the identification of cardiac diseases for which cell engraftment may be most beneficial. In parallel to the numerous experimental studies designed to address these issues, initial clinical trials are underway or in preparation and it is mandatory to design and conduct them in a careful manner so as to ultimately know whether cellular transplantation holds its promise as a means of improving the outcomes of patients with heart failure.
Collapse
Affiliation(s)
- Philippe Menasché
- Department of Cardiovascular Surgery, Hôpital Bichat Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
21
|
Menasché P, Desnos M. Cardiac reparation: fixing the heart with cells, new vessels and genes. Eur Heart J Suppl 2002. [DOI: 10.1093/ehjsupp/4.suppl_d.d73] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
22
|
Horvath KA, Belkind N, Wu I, Greene R, Doukas J, Lomasney JW, McPherson DD, Fullerton DA. Functional comparison of transmyocardial revascularization by mechanical and laser means. Ann Thorac Surg 2001; 72:1997-2002. [PMID: 11789783 DOI: 10.1016/s0003-4975(01)03243-x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
BACKGROUND As a result of the clinical benefit observed in angina patients treated by transmyocardial revascularization (TMR) with a laser, interest in mechanical TMR has been renewed. Although the injury induced by mechanical TMR is similar to laser TMR, the resultant impact on myocardial contractility is unknown. The purpose of this study was to determine whether mechanical TMR improves ventricular function as compared with laser TMR in chronically ischemic myocardium. METHODS After establishing an area of chronic myocardial ischemia, 25 domestic pigs were randomized to treatment by: excimer laser (group I), a hot needle (50 degrees C) (group II), a normothermic needle (group III), an ultrasonic needle (40 KHz) (group IV), or no treatment (group V). All devices create a transmural channel of the same diameter; 22 +/- 1 transmural channels were created in each animal. Regional myocardial contractility was assessed by measuring ventricular wall thickening at rest and with dobutamine stress echocardiography. Six weeks after revascularization, the animals were restudied at rest and with stress. Postsacrifice and histologic analysis of angiogenesis and TMR effects was then assessed. RESULTS Laser TMR provided significant recovery of ischemic myocardial function. This improvement in contractility after laser TMR was a 75% increase over the baseline function of the ischemic zone (p < 0.01). Mechanical TMR provided no significant improvement in function posttreatment. In fact, TMR achieved with an ultrasonic needle demonstrated a 40% worsening of the contractility versus the pretreatment baseline (p < 0.05). Histologic analysis demonstrated a significant increase in new blood vessels in the ischemic zone after laser TMR, which was not demonstrated for any of the other groups (p < 0.05). Additionally, evaluation of the mechanical TMR channels demonstrated significant scarring, which correlated with the functional results. CONCLUSIONS Using devices to create an injury analogous to the laser, mechanical TMR failed to improve the function of chronically ischemic myocardium. Only laser TMR significantly improved myocardial function.
Collapse
Affiliation(s)
- K A Horvath
- Division of Cardiothoracic Surgery, Northwestern University Medical School, Chicago, Illinois 60611, USA.
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Díaz De Tuesta I, Martínez R. [Coronary artery bypass graft combined with transmyocardial laser revascularization. Survival and functional class at one-year follow-up]. Rev Esp Cardiol 2001; 54:1295-304. [PMID: 11707240 DOI: 10.1016/s0300-8932(01)76500-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
INTRODUCTION AND OBJECTIVES The use of Transmyocardial Laser Revascularization (TMLR) as a strategy to treat unstable angina has been reported in many studies. We analyze its safety and effectiveness in combined procedures (CABG + TMLR). METHODS A non-randomized, retrospective cohort study was performed from May 4, 1999 to May 25, 2000 in 21 TMLR patients (18 combined CABG + TMLR) and 118 CABG only procedures. Mortality and NYHA analyses were determined by telephone at follow-up. RESULTS Three hospital deaths were observed: one isolated TMLR patient, one valvular + CABG + TMLR patient, and one CABG + TMLR patient. A significantly higher incidence of preoperative angina was found in the group of patients with TMLR + CABG, than in the group with only CABG (83 vs 25%; p < 0.001). There were no differences in age, gender, ejection fraction, Parsonnet and EuroSCORE risk estimation, or mortality (5.1% isolated CABG, 5.6% combined). No episode of angina was detected during follow-up in the CABG + TMLR group: 88% patients were NYHA I, and 21% NYHA II. CONCLUSION Incomplete coronary revascularization may be complemented with TMLR in the areas in which CABG is not possible without increased mortality. This technique may avoid postoperative unstable angina due to residual ischemic areas.
Collapse
Affiliation(s)
- I Díaz De Tuesta
- Hospital Universitario de Canarias, 38190 La L aguna, SC Tenerife.
| | | |
Collapse
|
24
|
Shehada RE, Papaioannou T, Mansour HN, Grundfest WS. Excimer laser (308 nm) based transmyocardial laser revascularization: effects of the lasing parameters on myocardial histology. Lasers Surg Med 2001; 29:85-91. [PMID: 11500869 DOI: 10.1002/lsm.1092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND AND OBJECTIVE The effect of the excimer laser (308 nm) parameters on transmyocardial revascularization (TMR) channels is not well defined. This study investigates the influence of the pulse repetition rate, the size of the delivery catheter and its advancement speed on the morphology of TMR channels in vivo. STUDY DESIGN/MATERIALS AND METHODS Myocardial ablation was performed in a porcine model (N = 27) using multifiber catheters of 1.0 and 1.4 mm in diameter. The catheters were advanced into the myocardium at different speeds (1.27 and 2.54 mm/sec) while ablating at various repetition rates (10-80 Hz). The radiant exposure was kept at 35 mJ/mm(2) throughout the experiments. The channel histology was quantified by digital microscopy. RESULTS The channel cross-sectional area and the extent of the thermal damage decrease as the catheter advancement speed exceeds the ablation speed and vice versa. Within the parameters tested, advancement speed of about 1.3 mm/sec and pulse repetition rates of 40 Hz produce channels of size comparable to the catheter's diameter with moderate thermomechanical damage. CONCLUSIONS The repetition rate, catheter size, and catheter advancement speed are closely intertwined and crucial to the histological outcome of excimer laser based TMR.
Collapse
Affiliation(s)
- R E Shehada
- Laser Research and Technology Development, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
| | | | | | | |
Collapse
|
25
|
Saito T, Pelletier MP, Shennib H, Giaid A. Nitric oxide system in needle-induced transmyocardial revascularization. Ann Thorac Surg 2001; 72:129-36. [PMID: 11465166 DOI: 10.1016/s0003-4975(01)02687-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND Nitric oxide (NO) promotes endothelial proliferation and migration, essential for angiogenesis. The purpose of this study was to determine the cellular expression of inducible and endothelial nitric oxide synthases (iNOS and eNOS) in an ischemic cardiomyopathy animal model of needle-induced transmyocardial revascularization (TMR). METHODS Myocardial infarction was created in rats by ligating the left coronary artery, and animals were divided into two groups: no-TMR group (served as control) and TMR group (underwent concomitant TMR by the creation of six transmural channels with a 25-gauge needle in the ischemic area). Rats were sacrificed at intervals of 1, 2, 4, and 8 weeks. Immunohistochemistry using specific antisera was performed for iNOS, eNOS, and endothelial cell marker factor VIII. Vascular density and positive staining area with either iNOS or eNOS were assessed in the infarcted myocardium. RESULTS Vascular density in the infarcted myocardium was significantly increased in the TMR group (p < 0.001). The positive staining area for iNOS and the intensity of iNOS immunoreactivity in cardiomyocytes, vascular endothelium, and macrophages were significantly greater in the TMR group (p < 0.05). However, these differences were seen only in the first 2 weeks after TMR. There was no significant difference in the expression of eNOS between groups. CONCLUSIONS A mechanical injury using needle puncture in an ischemic myocardium increased vascular density and is associated with increased expression of myocardial iNOS. Increased production of NO derived from iNOS may contribute to the angiogenic response of TMR.
Collapse
Affiliation(s)
- T Saito
- Department of Pathology, The Montreal General Hospital, McGill University, Quebec, Canada
| | | | | | | |
Collapse
|
26
|
Lutter G, Martin J, von Samson P, Heilmann C, Sarai K, Beyersdorf F. Microperfusion enhancement after TMLR in chronically ischemic porcine hearts. CARDIOVASCULAR SURGERY (LONDON, ENGLAND) 2001; 9:281-91. [PMID: 11336852 DOI: 10.1016/s0967-2109(00)00135-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVE The purpose of this study was to determine the effect of transmyocardial laser revascularization (TMLR) on myocardial perfusion and function in chronically ischemic myocardium. METHODS In the first operation a stenosis of the left anterior descending artery was created in 20 open-chest anesthetized pigs to implement this ischemic model. In contrast, four pigs served as controls (thoracotomy only). Seven days later (2nd operation), all animals were studied at baseline by analyzing different parameters of perfusion (radioactive microspheres), function, and intramyocardial pressure. Afterwards, pigs who received a left anterior descending artery stenosis were randomized into one of three groups: animals in laser group 1 (n=7) received one and in laser group 2 (n=7) two laser channels per cm(2) in the left anterior descending artery territory. Animals of the ischemic group (n=6) underwent the same procedures without transmyocardial laser revascularization. Three months later, the animals were re-studied (3rd operation) and additional analysis of histochemistry and myocardial water content was performed. RESULTS Regional myocardial blood flow (RMBF) in laser group 2 revealed statistically higher RMBF values compared to the ischemic group (0.39+/-0.13 versus 0.14+/-0.12 ml/min/g; P=0.043), after 3 months, whereas the absolute RMBF had not increased compared to the 1-week baseline values. Left ventricular stroke work index (LVSWI) at rest and under stress did not show any improvement compared to the initial values in all study groups (P=ns). Nevertheless, laser group 1 demonstrated relatively higher LVSWI(max) values compared to the ischemic (1.33+/-0.19 versus 0.93+/-0.16 mJ/kg; P=0.03) and laser group 2 (1.33+/-0.19 versus 1.02+/-0.15; P=0.024). Regional contractility of laser groups 1 and 2 recovered after 3 months (which had deteriorated shortly after transmyocardial laser revascularization) and increased under stress (100% versus 144.33+/-46.42, P=0.029 and 100% versus 116.26+/-21.06, P=0.034; respectively). In contrast, the corresponding ischemic group values were not different from initial values (P=ns). CONCLUSIONS This model of chronic regional ischemia demonstrates that CO(2)-laser revascularization significantly improves microperfusion and regional function, whereas the overall perfusion and global LV function is unchanged.
Collapse
Affiliation(s)
- G Lutter
- Division of Cardiovascular Surgery, Albert-Ludwigs-University, School of Medicine, Freiburg, Germany.
| | | | | | | | | | | |
Collapse
|
27
|
Xu X, Li J, Simons M, Li J, Laham RJ, Sellke FW. Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia. J Thorac Cardiovasc Surg 2001; 121:735-42. [PMID: 11279416 DOI: 10.1067/mtc.2001.112340] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND Vascular endothelial growth factor, a specific endothelial mitogen, plays an important role in myocardial angiogenesis. Previous work has demonstrated increased expression of vascular endothelial growth factor and its receptors in a rat myocardial infarction model, as well as in a pig model of chronic ischemia. The expression of vascular endothelial growth factor and other growth factors after acute myocardial ischemia in patients has not been examined. In this study we examined the expression of vascular endothelial growth factor and its receptors and the responsiveness of human atrial microvessels to vascular endothelial growth factor before and after acute ischemia. METHODS Paired specimens of human atrial tissue were harvested before and after atrial devascularization (ligation) in 16 patients undergoing coronary bypass operations. RESULTS The messenger RNA (reverse transcriptase-polymerase chain reaction) level of vascular endothelial growth factor and vascular endothelial growth factor receptor 1 were increased by 22.2% +/- 4.2% and 30.7% +/- 7.6%, respectively (P <.05), in the ischemic specimens as compared with the control specimens. Protein expression (Western blotting) of vascular endothelial growth factor and that of vascular endothelial growth factor receptor 1 also were increased significantly by 71.7% +/- 27.8% and 68.2% +/- 27.6%, respectively (P <.05). However, both RNA and protein expressions of another vascular endothelial growth factor receptor, vascular endothelial growth factor receptor 2, and fibroblast growth factor and fibroblast growth factor receptor 1 were unchanged. Reactivity of precontracted atrial vessels was examined with video microscopy. Vascular endothelial growth factor-induced (33.9% +/- 2.4% vs 18.3% +/- 2.8% in control and ischemic vessels, respectively; P <.05), fibroblast growth factor-induced (31.6% +/- 3.2% vs 15.8% +/- 4.1%, P <.05), and substance P-induced (84.5% +/- 3.7% vs 54.3% +/- 9.0%, P <.05) microvascular relaxations were decreased in ischemic samples and in the presence of N (G)nitro-L -arginine, whereas responses to sodium nitroprusside were unchanged (90.9% +/- 2.2% vs 91.2% +/- 2.0%). CONCLUSIONS This study suggests that acute myocardial ischemia in patients results in increased expression of vascular endothelial growth factor but not fibroblast growth factor and that the functional activity of vascular endothelial growth factor receptors and that of other growth factors may be impaired.
Collapse
MESH Headings
- Acute Disease
- Biomarkers
- Blotting, Western
- Coronary Artery Bypass
- Coronary Circulation/drug effects
- Coronary Circulation/physiology
- Coronary Vessels/metabolism
- Coronary Vessels/physiopathology
- DNA Probes/chemistry
- Endothelial Growth Factors/genetics
- Endothelial Growth Factors/metabolism
- Enzyme Inhibitors
- Female
- Gene Expression
- Heart Atria/metabolism
- Humans
- Lymphokines/genetics
- Lymphokines/metabolism
- Male
- Middle Aged
- Myocardial Ischemia/metabolism
- Myocardial Ischemia/physiopathology
- Myocardial Ischemia/surgery
- Nitroarginine
- Nitroprusside
- Prognosis
- Protein Isoforms/genetics
- Protein Isoforms/metabolism
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Receptor Protein-Tyrosine Kinases/genetics
- Receptor Protein-Tyrosine Kinases/metabolism
- Receptor, Fibroblast Growth Factor, Type 1
- Receptors, Fibroblast Growth Factor/genetics
- Receptors, Fibroblast Growth Factor/metabolism
- Receptors, Growth Factor/genetics
- Receptors, Growth Factor/metabolism
- Receptors, Mitogen/genetics
- Receptors, Mitogen/metabolism
- Receptors, Vascular Endothelial Growth Factor
- Reverse Transcriptase Polymerase Chain Reaction
- Substance P/genetics
- Substance P/metabolism
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
- Vasodilation/drug effects
- Vasodilation/physiology
- Vasodilator Agents
Collapse
Affiliation(s)
- X Xu
- Harvard Medical School and the Division of Cardiothoracic Surgery and Angiogenesis Research Center, Beth Israel Deaconess Medical Center, 110 Francis St., Boston, MA 02215, USA
| | | | | | | | | | | |
Collapse
|
28
|
Pouzet B, Vilquin JT, Hagège AA, Scorsin M, Messas E, Fiszman M, Schwartz K, Menasché P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001; 71:844-50; discussion 850-1. [PMID: 11269463 DOI: 10.1016/s0003-4975(00)01785-9] [Citation(s) in RCA: 135] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND This study assessed the extent to which the initial degree of functional impairment and the number of injected cells may influence the functional improvement provided by autologous skeletal myoblast transplantation into infarcted myocardium. METHODS One week after left coronary artery ligation, 44 rats received into the infarcted scar, autologous skeletal myoblasts expanded in vitro for 7 days (mean, 3.5 x 10(6), n = 21), or culture medium alone (controls, n = 23). Left ventricular function was assessed by two-dimensional echocardiography. RESULTS When transplanted hearts were stratified according to their baseline ejection fraction, a significant improvement occurred at 2 months in the less than 25% (from 21.4% to 37%), 25% to 35% (from 29% to 43.8%), and in the 35% to 40% (from 37.2% to 41.7%) groups, compared to controls (p = 0.048, 0.0057, and 0.034, respectively), but not in the more than 40% stratum. A significant linear relationship was found between the improvement in ejection fraction and the number of injected myoblasts, both at 1 and 2 months after transplantation (p < 0.0001). CONCLUSIONS Autologous myoblast transplantation is functionally effective over a wide range of postinfarct ejection fractions, including in the sickest hearts provided that they are injected with a sufficiently high number of cells.
Collapse
Affiliation(s)
- B Pouzet
- Department of Cardiovascular Surgery, H pital Bichat, INSERM U523, Institut de Myologie, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
29
|
de la Torre JC. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci 2001; 924:136-52. [PMID: 11193790 DOI: 10.1111/j.1749-6632.2000.tb05572.x] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
After nearly a century of inquiry, the cause of Alzheimer's disease (AD) remains to be found. In this review, basic and clinical evidence is presented that assembles and hypothetically explains most of the key pathologic events associated with the development of AD. These pathologic events are triggered in AD by impaired cerebral perfusion originating in the microvasculature that affects the optimal delivery of glucose and oxygen and results in an energy metabolic breakdown of brain cell biosynthetic and synaptic pathways. We propose that two factors must be present before cognitive dysfunction and neurodegeneration is expressed in the AD brain: (1) advanced aging, (2) presence of a condition that lowers cerebral perfusion, such as a vascular risk factor. The first factor introduces a normal but potentially menacing process that lowers cerebral blood flow in proportion to increased aging, while the second factor adds a crucial burden that further lowers brain perfusion and places vulnerable neurons in a state of metabolic compromise leading to a death pathway. These two factors will lead to a critically attained threshold of cerebral hypoperfusion (CATCH). CATCH is a self-sustaining and progressive circulatory insufficiency that will destabilize neurons, synapses, neurotransmission, and cognitive function, creating in its wake a neurodegenerative process characterized by the formation of senile plaques, neurofibrillary tangles, amyloid angiopathy, and, in some cases, Lewy bodies. Since any of a considerable number of vessel-related conditions must be present in the aging individual for cognition to be affected, CATCH supports the heterogeneic disease profile assumed to be characteristic of the AD syndrome. A brief discussion of target therapy based on the proposed pathogenesis of AD is also reviewed.
Collapse
Affiliation(s)
- J C de la Torre
- Department of Neuroscience, University of California, San Diego, La Jolla, California 92093, USA.
| |
Collapse
|
30
|
Dzau VJ, Mann MJ, Ehsan A, Griese DP. Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics. J Thorac Cardiovasc Surg 2001; 121:206-16. [PMID: 11174725 DOI: 10.1067/mtc.2001.111211] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- V J Dzau
- Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, USA
| | | | | | | |
Collapse
|
31
|
Abstract
Despite the proven effectiveness of coronary bypass surgery and percutaneous angioplasty techniques, an increasing number of patients are presenting with severe, medically intractable angina who are not candidates for either procedure. Two alternative strategies, transmyocardial laser revascularization and exogeneous administration of angiogenic growth factors (therapeutic angiogenesis) are currently being evaluated in such patients. This review focuses on the current status of these two procedures, emphasizing their similarities and differences in order to provide insight into what role each may ultimately play in the management of patients with otherwise unrevascularizable myocardial ischemia.
Collapse
Affiliation(s)
- J F Symes
- St. Elizabeth's Medical Center, 11 Nevins Street, Boston, MA 02135, USA
| |
Collapse
|